Papers
1
Total Citations
6
H-Index
1
About
Seydou Sanogo is a pharmaceutical scientist whose research focuses on the physicochemical stability and compatibility of intravenous drug formulations, particularly in oncology and supportive care. His major contributions lie in generating critical stability data that enable the safe, centralized, and extended preparation of high-risk injectable medications, reducing waste and improving patient safety. His most-cited work, a 2020 study on calcium levofolinate (CaLev), demonstrated that this chemotherapeutic adjuvant remains stable for up to 14 days when reconstituted in syringes and diluted in both NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags. This finding directly addressed a critical gap in pharmaceutical practice, as the lack of stability data previously forced hospitals into costly, error-prone extemporaneous manual preparations. By providing evidence for extended beyond-use dating, Sanogo’s work supports the implementation of centralized intravenous additive services (CIVAS) and batch production, ultimately enhancing workflow efficiency and medication safety in clinical settings. His research, with over 6 citations on this single paper, is essential reading for hospital pharmacists, pharmaceutical technologists, and researchers focused on the stability of labile anticancer drugs.
Research Focus
Key Achievements
Top Papers
- 1